OPS
NTLA icon

Orion Portfolio Solutions’s Intellia Therapeutics NTLA Stock Holding History

Orion Portfolio Solutions’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-98
Closed -$1K – 2169
2019
Q4 		$1K Buy
+98
New +$1.36K ﹤0.01% 1694

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Orion Portfolio Solutions's NTLA Position: Q1 2020 in Review

Orion Portfolio Solutions sold out of Intellia Therapeutics (NTLA) in Q1 2020, closing a stake of 98 shares — an estimated $1K sold.

Orion Portfolio Solutions first reported a position in NTLA in Q4 2019 and held it in 1 quarter. The position peaked at $1K in Q4 2019. 140 funds tracked by Wall St. Rank hold NTLA as of Q1 2020.

  • Orion Portfolio Solutions reported no remaining Intellia Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Orion Portfolio Solutions sold 98 Intellia Therapeutics shares in Q1 2020, an estimated $1K.
  • Orion Portfolio Solutions first reported a position in Intellia Therapeutics in Q4 2019 and held it in 1 quarter.
  • Orion Portfolio Solutions's Intellia Therapeutics position peaked at $1K in Q4 2019.
  • 140 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2020.

Based on Orion Portfolio Solutions's 13F filing for Q1 2020, filed 15 May 2020.